Journal Article

Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study: reply

Gilles Montalescot

in European Heart Journal

Published on behalf of European Society of Cardiology

Volume 27, issue 12, pages 1509-1509
Published in print June 2006 | ISSN: 0195-668x
Published online May 2006 | e-ISSN: 1522-9645 | DOI: http://dx.doi.org/10.1093/eurheartj/ehl009
Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study: reply

Show Summary Details

Journal Article.  479 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.